Ex-Biopure CEO Settles Blood Substitute Case
Biopure Corp.'s former chief executive has resolved allegations that the pharmaceutical company continued to paint a rosy picture of its blood substitute awaiting approval, despite receiving negative feedback from U.S. federal...To view the full article, register now.
Already a subscriber? Click here to view full article